The duration and frequency of chemotherapy administration are meticulously determined by a medical oncology specialist. This decision is based on a comprehensive assessment, including the type and extent of the tumor, the patient's age, overall health, and existing medical conditions such as cardiac issues, hypertension, diabetes, or renal disease. The medical oncologist also establishes the specific dosages and administration schedule for the chosen therapeutic agents. The overall treatment plan, encompassing its duration and frequency, is highly individualized, reflecting the patient's unique condition and the disease's characteristics. Adjustments to the duration and frequency may be made throughout the treatment course, contingent upon the patient's response and the management of any side effects. While typical intervals often range from 3 to 4 weeks, certain regimens may necessitate weekly or bi-weekly applications. Maintaining the recommended chemotherapy schedule is critical; treatment should be administered as regularly as possible, provided side effects are manageable. Unwarranted delays in treatment intervals can inadvertently afford the tumor an opportunity to recover, develop resistance to the drugs, and proliferate. Such delays risk continued disease progression and diminished treatment effectiveness. Consequently, strict adherence to the medical oncologist's guidance regarding the timing of chemotherapy sessions is essential.